Physician

Abdallah Mohamed Jeroudi, MD

According to 2025 Medicare claims, Abdallah Jeroudi, MD (NPI: 1730479650) practices ophthalmology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Flagler, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 32137-4757.

Jeroudi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,231 traditional Medicare patients, billed 31,995 HCPCS/CPT codes, and received $3,751,823 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,108 prescription claims across 313 beneficiaries totaling $582,720 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 12 records totaling $410. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,217 to $3,751,823. Similarly, Part D prescription costs have moved sharply higher in recent years, from $5,067 to $582,720. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2015 Medicare payment: $10,217 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $19,808 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $134,693 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $898,172 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,471,568 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,721,449 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,948,463 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,527,283 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,392,534 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,751,823 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157487$10,217
2016139173$19,808
20174191,708$134,693
20189138,413$898,172
20199299,775$1,471,568
20209429,713$1,721,449
202194510,237$1,948,463
20221,07013,927$2,527,283
20231,33430,565$3,392,534
20241,23131,995$3,751,823

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$380K$759K2015 Drug cost: $5,067 (USD; Tot_Drug_Cst)2016 Drug cost: $2,768 (USD; Tot_Drug_Cst)2017 Drug cost: $6,420 (USD; Tot_Drug_Cst)2018 Drug cost: $55,642 (USD; Tot_Drug_Cst)2019 Drug cost: $140,050 (USD; Tot_Drug_Cst)2020 Drug cost: $284,343 (USD; Tot_Drug_Cst)2021 Drug cost: $268,978 (USD; Tot_Drug_Cst)2022 Drug cost: $638,945 (USD; Tot_Drug_Cst)2023 Drug cost: $759,378 (USD; Tot_Drug_Cst)2024 Drug cost: $582,720 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201560121$5,067
201698138$2,768
201793193$6,420
2018133470$55,642
2019161605$140,050
2020194763$284,343
2021210786$268,978
20222561,016$638,945
20233041,227$759,378
20243131,108$582,720

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3583,164$647
67028Injection of drug into eye4701,974$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7801,101$66
92134Imaging of retina8422,301$29
92250Photography of the retina598654$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept1243,974$332,986
Eylea HdAflibercept29952$91,875
SyfovrePegcetacoplan/Pf16448$43,800
VabysmoFaricimab-Svoa17490$37,449
ProlensaBromfenac Sodium28878$10,004

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$410Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdallah Mohamed Jeroudi, MD?

Tedicare shows public-source Medicare data for Abdallah Mohamed Jeroudi, MD (NPI 1730479650), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdallah Mohamed Jeroudi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdallah Mohamed Jeroudi, MD?

Abdallah Mohamed Jeroudi, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Abdallah Mohamed Jeroudi, MD have Open Payments data?

Abdallah Mohamed Jeroudi, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.